Subscribe to Nycomed

The Lead

Teva to Pay Pfizer and Nycomed $1.6B

June 12, 2013 9:27 am | News | Comments

Teva Pharmaceutical Industries Ltd. announced today that it has entered into a settlement agreement with Wyeth/Pfizer and Altana/Nycomed to resolve all claims relating to Teva’s sales, commencing in December 2007, of its 20 mg and 40 mg generic Protonix ® (pantoprazole sodium) tablets.

Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth

January 18, 2012 2:59 am | News | Comments

Takeda Pharmaceutical Company Limited announced today strategic measures to better align its...

Takeda Completes Acquisition and Names New CEO of Nycomed

September 30, 2011 4:31 am | News | Comments

Takeda Pharmaceutical Company Limited announced it has completed its acquisition of Nycomed A/S...

Eurand, Nycomed Reach Marketing Deal for Zenpep

January 12, 2011 3:41 am | News | Comments

Eurand N.V. has reached an agreement with Nycomed to sell and distribute Zenpep in Russia and the...

View Sample

FREE Email Newsletter

Nycomed Names New Vice-President, Business Development and Strategy

August 6, 2010 4:22 am | News | Comments

Nycomed US Inc. has announced the appointment of Jeff Wasserstein as its new Sr. Vice President, Business Development and Strategy

Nycomed Names New Chief Executive Officer

July 19, 2010 5:10 am | News | Comments

Nycomed US Inc. today   announced the appointment of Steve Andrzejewski as the new Chief   Executive Officer. He assumes immediate responsibility for Nycomed US   Inc., including manufacturing in Melville and Hicksville, New York,   distribution and commercial operations for the three marketing and   sales divisions Fougera, PharmaDerm and Savage Laboratories.

Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid

July 19, 2010 4:35 am | News | Comments

Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc .


Forest Laboratories, Nycomed Sign Marketing Deal

August 10, 2009 4:33 am | News | Comments

NEW YORK (AP) —Forest Laboratories Inc. said Monday it signed a deal to sell Nycomed's developing chronic bronchitis drug Daxas in the U.S. Under the deal, Forest Laboratories will pay Nycomed $100 million up front, plus future milestone payments. Nycomed will also receive royalties on U.S.

Report: Swiss Drugmaker Nycomed Shopping Itself

March 24, 2009 4:40 am | News | Comments

NEW YORK (AP) — Swiss drug company Nycomed could be in the market sell itself for as much as 10 billion euro, or $13.57 billion, according to a media report Monday.

BioSante Pharmaceuticals Reacquires Elestrin

August 8, 2008 7:37 am | News | Comments

BioSante Pharmaceuticals, Inc. has reacquired Elestrin (estradiol gel) from Nycomed US who in February 2008 acquired Bradley Pharmaceuticals, Inc., BioSante’s previous licensee of Elestrin. BioSante will immediately assume all manufacturing, distribution and marketing responsibilities for Elestrin.

Medimetriks Pharmaceuticals, Inc. Begins Operations

May 14, 2008 10:45 am | News | Comments

Medimetriks Pharmaceuticals, Inc. recently announced that it has commenced operations. The

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.